creased significantly (p < 0.05). Urokinase-type PA was increased significantly at 12 and 24 h and 5 days, while tissue-type PA was decreased significantly at I, 12, and 24 h in the ischemic compared with the nonischemic hemisphere. Gelatinase B was markedly increased in SHR at 12 and 24 h compared with WKY (p < 0.05).
Secondary vasogenic edema is maximal 1-2 days after a stroke, which is the time that gelatinase B was elevated. The time of appearance of ge1atinase B suggests a role in secondary tissue damage and vasogenic edema, while ge latinase A may be involved in tissue repair. Key Words: Blood-brain barrier-Cerebral edema-Cerebral isch emia-Matrix metalloproteinases-Plasminogen activa tors-Type IV collagenases. a consequence of the disruption of the extracellular matrix, the blood-brain barrier is opened, allowing vasogenic brain edema to accumulate.
Cerebral blood vessels are surrounded by a basal lamina composed of type IV collagen, fibronectin, heparan sulfate, and laminin (McArdle et aI. , 1984) . Intracerebral injection of activated 72-kDa type IV collagenase (gelatinase A) caused an increase in capillary permeability and a thinning of the basal lamina (Rosenberg et aI. , 1992) . This suggested that endogenous production of matrix-degrading metal loproteinases (MMP) and urokinase-type plasmino gen activator (uP A) could participate in a proteolyt ic cascade. Cancer cells employ such a proteolytic cascade to digest basement membranes, allowing metastatic cells to spread across blood vessels (Li otta et aI. , 1980) . During hemorrhagic injury in rat brain, increases occur in 92-kDa type IV collage nase (gelatinase B) and uPA, which are maximal at 16-24 h (Rosenberg et aI. , 1994) . Bo th the MMP and uPA genes have AP-l-binding sites in their pro moter regions that bind dimers formed from prod ucts of the immediate early genes c-fos and c-jun and initiate production of MMP and uP A (Sato and Seiki, 1993) . Cytokines act similarly (Brenner et aI. , 1989) . Ischemic injury causes an increase in both the early immediate genes and various cytokines, including tumor necrosis factor-a (Liu et aI. , 1993 (Liu et aI. , , 1994 . Therefore, we hypothesized that proteolytic cascade enzymes were induced by ischemic injury. Br ain tissue from rats subjected to permanent mid dle cerebral artery occlusion (MCAO) was tested by zymography for MMP and uP A from 1 h to 5 days after ischemia.
METHODS

Animal preparation
Thirty-three adult spontaneously hypertensive (SHR) or Wi star-Kyoto (WKY) rats were used in the study. They had permanent MCAO as previously described (Barone et aI., 1991) . In brief, SHR or WKY, weighing 250--350 g, were anesthetized with sodium pentobarbital (60 mg/kg IP) before surgery to occlude the middle cere bral artery. Animals were housed and cared for in accor dance with the Guide fo r the Care and Use of Lahoratory Animals (Bethesda, MD: Office of Science and Health Reports, DRRlNIH, 1985) . Procedures using laboratory animals were approved by the Institutional Animal Care and Use Committee of SmithKline Beecham Pharmaceu ticals.
Briefly, after a 2-to 3-mm craniotomy over the right MCA and removal of the dura, the hooked tip of a plat inum-iridium wire mounted on a micromanipulator was placed under the MCA and the artery was pulled 0.5-\.0 mm away from the brain surface. The artery was then simultaneously occluded and cut dorsally to the lateral olfactory tract at the level of the inferior cerebral vein. Later, rats that had recovered were overdosed with pen tobarbital and forebrains were removed and dissected as described previously at different times after MCAO (Liu et aI., 1993 (Liu et aI., , 1994 Barone et aI., 1991 ). An ipsilateral hemisphere (ischemic cortex) and an identical segment from the contralateral cortical hemisphere (non ischemic cortex) were dissected and immediately frozen in liquid nitrogen and stored at -80°C.
Twenty-one SHR were studied. Control tissue for time o was obtained from unoperated rats (n = 3). Three SHR were studied at 1, 3, 12, and 24 h and 5 days after surgery. WKY rats were studied at 12 (n = 3) and 24 (n = 6) h after surgery. An additional three SHR rats were studied at 24 h for comparison of the effect of ischemia on pro teolytic cascade enzyme production between SHR and WKY. Three WKY were studied 24 h after sham operation.
Proteolytic enzyme measurements
Brain tissue was removed and sectioned into four pieces. One section was in the region of maximal damage from the infarction. Another was dorsal to that region in the ipsilateral hemisphere. Two additional sections were taken from the opposite hemisphere in the same regions as on the infarcted side. Zymograms were done as de-scribed earlier (Rosenberg et aI., 1994) . Brains were re moved, frozen, and trimmed to obtain tissue from the regions of interest. Tissue samples were immediately weighed, and a volume of 0.5% Triton X-l00 in 20 mM phosphate-buffered saline (pH 7.0) was added to bring the final concentration to 400 mg/ml. Tissue samples were minced and left in solution at 4°C for 24 h. After centrif ugation, the supernatant was drawn off and stored at -70°C for zymography. Sodium dodecyl sulfate (SDS) was added for electrophoresis: Five microliters of super natant was mixed with 3 J.11 TRIS buffer (l.5 M, pH 8.8) and 2 J.11 of SDS buffer (55% distilled water; 12.5% of 0.5 M TRIS-HCI, pH 6.8; 10% glycerol; 20% SDS in a 10% w/v solution; and 2.5% bromophenol blue in a 0.05% w/v solution). Polyacrylamide minigels (10%) were prepared with gelatin copolymerized into the gels. Protein stan dards and HTI080 fibrosarcoma cell media were treated similarly before loading onto the gels. Following electro phoresis, all gels were agitated in 2.5% Triton X-IOO to remove SDS and incubated at 37°C for 24 h. For detection of PAs, casein and plasminogen were copolymerized into the gels instead of gelatin. Gels were stained for 1 h in 50010 methanol/l % acetic acid with 0.125% Coumassie G-250, then destained in 10% acetic acid. Protease activ ity on the zymograms appears as a clear zone where the enzyme has dissolved the substrate.
Data analysis
Dried gels were scanned by computer (HP ScanJet IIc; Hewlett-Packard, Palo Alto, CA, U.S.A.). Computer im age analysis software (NIH Image: v1.56) was used to analyze gels on a Macintosh Power PC computer. Images were analyzed with the electrophoretic gel lane calcula tion option in the program. Standardization was done with an optical density step tablet. Protein content was assayed by the micro BCA method (Pierce, Rockford, IL, U.S.A.). Results were expressed as area of lysis zone absorbance divided by protein content.
Statistical analysis of the data was done by either an analysis of variance (ANOV A), with the Waller-Duncan K ratio used to correct for multiple t tests, or, when appropriate, by Student's t test, using Statistical Analysis System (SAS, Cary, NC, U.S.A.). Significance was taken as p < 0.05.
RESULTS
A representative zymogram of rat brain tissue re moved and processed at different times in the in farct is shown in Fig. I . The lower band at 72 kDa in the zymograms shows gelatinase A in the tissue. Low levels of gelatinase A are seen in both hemi spheres until 5 days after infarction. The upper band at 92 kDa represents gelatinase B, which is seen to be present hours after injury. In unoperated SHR, low levels of both gelatinase A and B were found.
Measurements of the area of lysis in the zymo graphic gels revealed that gelatinase A was signifi cantly increased over the unoperated control rats at 5 days (p < 0. 05), while all other values were similar to those in the uninjured hemisphere (Fig. 2) . Gelat inase B in the region of the infarcted tissue in SHR was significantly elevated at 12 and 24 h only (p < 0.05). The value of gelatinase B at 5 days was also elevated compared with sham-operated controls, but it failed to reach statistical significance (Fig. 3) tion of uPA is shown in Fig. 4 . Two distinct bands are observed. The upper band represents tissue type plasminogen activator (tPA), while the lower band is from uPA, uPA rose in the infarcted brain tissue, reaching significant levels by 12 h and max imal values at 5 days (Fig. 5) . tPA was highest in unoperated brain tissue and reduced in ischemic tis sue at 1, 12, and 24 h (Fig. 6) .
Comparison of proteolytic enzyme production in SHR and WKY was done 24 h after infarct. No differences were noted in the levels of gelatinase A * ., 55 c: between the two species. At 24 h, SHR had mark edly higher levels of gelatinase B than WKY in the region of the infarct (Fig. 7 A) . This increase in ge latinase B in SHR was seen at 12 h and was absent in sham-operated WKY (data not shown). compared with 4,0, 1,3, and 2), was removed nrior to statistical comparison of SHR and WKY. Simi larly, the highest data point in the SHR group was removed (22. 5 compared with 9, 14, 10, 8, and 12). Urokinase values in infarcted tissue were similar in the two rat strains, while tPA was lower in SHR than in WKY (Fig. 7B ) .
DISCUSSION
Permanent occlusion of the middle cerebral ar tery in SHR caused an increase in the levels of pro teolytic cascade enzymes gelatinase B and uroki nase. Increases in gelatinase B occurred 12 h after MCAO and remained significantly elevated at least for 24 h. Gelatinase A, however, remained un changed until 5 days after the ischemic event. uP A was increased at 12 and 24 h, reaching maximal levels at 5 days. The time of maximal increases in the enzymes corresponds with the time of vaso genic edema (Menzies et aI. , 1993) .
Intracerebral injection of activated gelatinase A opens the blood-brain barrier by attacking the ex tracellular matrix around cerebral capillaries (Rosenberg et aI., 1992) . Gelatinases A and B are produced by different gene mechanisms, but both attack macromolecules in the basal lamina (Woess ner, 1991) . Although a direct link between gelati nase B production and blood-brain barrier damage remains to be established, the production of gelati nase B when the blood-brain barrier is open sug gests an association.
Gelatinase B began to increase around 3 h after the onset of ischemia. Immediate early genes or cy tokines are elevated at that time and may have stim ulated MMP production by acting on the promoter region of th.e gene (Liu et aI. , 1994) . The long delay before an increase in gelatinase A eliminates a role J Cereb Blood Flow Metab, Vol. 16, No.3, 1996 in acute injury but suggests that it is involved in the recovery phase. Tumor necrosis factor-a induces the production of gelatinase B 24 h after intracere bral injection and causes secondary opening of the blood-brain barrier; capillary damage is blocked by a synthetic inhibitor of MMP (Rosenberg et aI., 1995) .
Other investigators have studied the effect of ischemia on the blood-brain barrier. Around 24 h after a permanent MCAO, there is an increase in brain water that corresponds with opening of the blood-brain barrier (Menzies et aI., 1993) . The in crease in brain water resolves over several days, while the increase in capillary permeability persists longer. In an earlier study of blood-brain barrier damage, using a model of intracerebral hemorrhage, capillary permeability to radiolabeled sucrose was increased for 7 days, resolving by 14 days. In the hemorrhagic model, secondary vasogenic brain edema resolved by 48 h, though the blood-brain barrier remained open longer (Rosenberg et aI. , 1990 (Rosenberg et aI. , , 1993 .
MMP are a gene family of zinc-containing en zymes (Sato and Seiki, 1993) . The promoter region of the gelatinase B gene has an AP-l binding site which responds to many stimuli, including Fos/Jun dimers and cytokines (Lefebvre et aI. , 1990) . Gelat inase B is released into the extracellular space in a latent form. Proteases and free radicals are possible activators of the latent enzymes, but the mecha nisms of activation in vivo are poorly understood. Several cytokines are increased in ischemia (Roth well and Relton, 1993; Feuerstein et aI., 1994) , par ticularly tumor necrosis factor-a and interleukin-1[3, which are significantly elevated 3-6 h post ischemia, peaking at 12 h (Liu et aI., 1993) .
The cell types involved in production in gelati nase B and uPA in vivo are uncertain. Antibodies to gelatinases and cDNA probes for the genes are not available for the rat, and studies localizing the en zymes cannot be done. In culture, many cells pro duce MMP, including microglial cells, astrocytes, endothelial cells, and mononuclear cells; stimula tion with phorbol esters, cytokines, or lipopolysac charides is required (Gottschall and Yo, 1995; Col ton et aI. , 1993) .
Gelatinase A was increased at 5 days, suggesting that it is involved in remodeling of the extracellular matrix. This is the time of elevation of transforming growth factor-[3, which is activated by plasmin and induces extracellular matrix production (Wang et aI. , 1995) . uPA was markedly increased at 5 days. Gelatinases and plasminogen activators act in cas cade to attack the basal lamina (Reich et aI., 1988; Reith and Rucklidge, 1992) . Such a process is im-portant in angiogenesis, which is beginning around that time (Folkman and Shing, 1992 ).
An interesting finding is that SHR produce much higher amounts of gelatinase B after MCAO than WKY. SHR have an exaggerated release of tumor necrosis factor-a after intracisternal or systemic in jection of lipopolysaccharide (Hallenbeck et aI., 1991; Siren et aI., 1993) . SHR have pathological changes in the blood vessels, including thickening of the basal lamina around capillaries (Fredriksson et aI., 1988) . Gelatin:lses may play a role in the fi brosis that appears after breakdown and repair of the extracellular matrix around the cerebral capil laries. Another difference between SHR and WKY was the lower levels of tP A in SHR. The signifi cance of this observation will remain uncertain until the role of tP A in the brain is determined.
Our results suggest that gelatinases and uPA par ticipate in secondary tissue damage after permanent MCAO. Elevated levels of gelatinase B occur when the blood-brain barrier is open, and gelatinase A is elevated when tissue repair is occurring. Activation of proteolytic enzymes may cause hemorrhagic transformation of the tissue after stroke. Agents that block the production or action of MMP may interfere with the development of secondary extra cellular matrix disruption after stroke and enhance recovery.
